Cocrystal Ev To Free Cash Flow vs Free Cash Flow Yield Analysis

COCP Stock

USD 2.35 0.03 1.29%

Cocrystal Pharma financial indicator trend analysis is way more than just evaluating Cocrystal Pharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cocrystal Pharma is a good investment. Please check the relationship between Cocrystal Pharma Ev To Free Cash Flow and its Free Cash Flow Yield accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Ev To Free Cash Flow vs Free Cash Flow Yield

Ev To Free Cash Flow vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cocrystal Pharma Ev To Free Cash Flow account and Free Cash Flow Yield. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Cocrystal Pharma's Ev To Free Cash Flow and Free Cash Flow Yield is -0.53. Overlapping area represents the amount of variation of Ev To Free Cash Flow that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Cocrystal Pharma, assuming nothing else is changed. The correlation between historical values of Cocrystal Pharma's Ev To Free Cash Flow and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Free Cash Flow of Cocrystal Pharma are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Ev To Free Cash Flow i.e., Cocrystal Pharma's Ev To Free Cash Flow and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

-0.53

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from Cocrystal Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 01/04/2025, Enterprise Value Multiple is likely to grow to 0.39, while Selling General Administrative is likely to drop slightly above 4.1 M.

	2022	2023	2024	2025 (projected)
Total Operating Expenses	18.1M	22.5M	25.9M	21.6M
Cost Of Revenue	241.6K	15.2K	13.7K	13.0K

Total Operating Expenses Cost Of Revenue

Cocrystal Pharma fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Other Current Liab	Property Plant And Equipment Net	Other Current Assets	Property Plant And Equipment Gross	Short Long Term Debt Total	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Short Term Debt
Total Assets		0.17	0.59	0.02	0.19	0.22	-0.08	0.96	-0.41	-0.07	0.56	-0.09	-0.15	0.77	-0.1	0.57	0.3	-0.42	-0.3	-0.4	-0.44	-0.16	0.66	0.41	-0.45	0.34
Total Current Liabilities	0.17		-0.31	0.43	0.61	0.03	-0.41	0.25	0.04	-0.41	0.12	-0.36	-0.64	0.46	-0.36	0.15	0.86	0.14	0.43	-0.03	0.16	-0.37	0.3	0.77	0.13	0.84
Total Stockholder Equity	0.59	-0.31		-0.2	-0.19	0.47	0.14	0.53	-0.67	0.14	0.68	0.14	0.46	-0.06	0.1	0.68	-0.22	-0.38	-0.27	-0.31	-0.51	0.09	0.51	-0.24	-0.49	-0.28
Net Debt	0.02	0.43	-0.2		0.75	0.02	-0.98	0.25	-0.14	-0.98	0.1	-0.79	-0.65	0.2	-0.97	0.14	0.28	0.01	-0.14	-0.33	0.48	0.28	0.34	0.27	0.45	0.46
Retained Earnings	0.19	0.61	-0.19	0.75		-0.14	-0.77	0.37	-0.13	-0.76	0.16	-0.49	-0.91	0.4	-0.77	0.25	0.47	-0.12	-0.16	-0.46	0.59	-0.24	0.35	0.48	0.6	0.77
Accounts Payable	0.22	0.03	0.47	0.02	-0.14		0.03	0.2	-0.31	0.03	0.38	-0.05	0.32	-0.1	0.02	0.34	-0.21	0.38	-0.24	0.3	-0.01	0.0	-0.09	-0.35	-0.07	-0.25
Cash	-0.08	-0.41	0.14	-0.98	-0.77	0.03		-0.32	0.19	1.0	-0.14	0.76	0.68	-0.23	1.0	-0.2	-0.3	0.15	0.16	0.49	-0.41	-0.23	-0.45	-0.32	-0.4	-0.51
Non Current Assets Total	0.96	0.25	0.53	0.25	0.37	0.2	-0.32		-0.44	-0.31	0.55	-0.24	-0.33	0.79	-0.34	0.6	0.34	-0.46	-0.35	-0.54	-0.31	-0.11	0.74	0.46	-0.32	0.44
Non Currrent Assets Other	-0.41	0.04	-0.67	-0.14	-0.13	-0.31	0.19	-0.44		0.19	-0.96	0.18	-0.12	0.02	0.2	-0.96	0.02	0.26	0.13	0.3	0.16	-0.24	-0.44	0.08	0.18	0.01
Cash And Short Term Investments	-0.07	-0.41	0.14	-0.98	-0.76	0.03	1.0	-0.31	0.19		-0.14	0.76	0.67	-0.21	1.0	-0.2	-0.29	0.15	0.16	0.49	-0.42	-0.24	-0.44	-0.31	-0.4	-0.49
Common Stock Total Equity	0.56	0.12	0.68	0.1	0.16	0.38	-0.14	0.55	-0.96	-0.14		-0.19	0.08	0.15	-0.14	0.98	0.15	-0.24	-0.06	-0.25	-0.22	0.08	0.47	0.08	-0.26	0.13
Common Stock Shares Outstanding	-0.09	-0.36	0.14	-0.79	-0.49	-0.05	0.76	-0.24	0.18	0.76	-0.19		0.42	-0.21	0.73	-0.15	-0.3	0.0	-0.12	0.12	-0.34	-0.4	-0.22	-0.26	-0.27	-0.39
Other Stockholder Equity	-0.15	-0.64	0.46	-0.65	-0.91	0.32	0.68	-0.33	-0.12	0.67	0.08	0.42		-0.58	0.67	-0.02	-0.54	0.12	0.13	0.42	-0.53	0.3	-0.26	-0.62	-0.56	-0.83
Total Liab	0.77	0.46	-0.06	0.2	0.4	-0.1	-0.23	0.79	0.02	-0.21	0.15	-0.21	-0.58		-0.23	0.18	0.55	-0.24	-0.18	-0.29	-0.13	-0.28	0.44	0.7	-0.16	0.65
Total Current Assets	-0.1	-0.36	0.1	-0.97	-0.77	0.02	1.0	-0.34	0.2	1.0	-0.14	0.73	0.67	-0.23		-0.21	-0.25	0.17	0.23	0.52	-0.41	-0.22	-0.45	-0.28	-0.4	-0.47
Common Stock	0.57	0.15	0.68	0.14	0.25	0.34	-0.2	0.6	-0.96	-0.2	0.98	-0.15	-0.02	0.18	-0.21		0.17	-0.3	-0.13	-0.38	-0.19	0.02	0.54	0.11	-0.21	0.19
Other Current Liab	0.3	0.86	-0.22	0.28	0.47	-0.21	-0.3	0.34	0.02	-0.29	0.15	-0.3	-0.54	0.55	-0.25	0.17		-0.25	0.61	-0.25	-0.14	-0.4	0.49	0.96	-0.19	0.89
Property Plant And Equipment Net	-0.42	0.14	-0.38	0.01	-0.12	0.38	0.15	-0.46	0.26	0.15	-0.24	0.0	0.12	-0.24	0.17	-0.3	-0.25		-0.06	0.88	0.49	0.16	-0.69	-0.39	0.43	-0.28
Other Current Assets	-0.3	0.43	-0.27	-0.14	-0.16	-0.24	0.16	-0.35	0.13	0.16	-0.06	-0.12	0.13	-0.18	0.23	-0.13	0.61	-0.06		0.18	-0.26	-0.11	0.01	0.47	-0.32	0.3
Property Plant And Equipment Gross	-0.4	-0.03	-0.31	-0.33	-0.46	0.3	0.49	-0.54	0.3	0.49	-0.25	0.12	0.42	-0.29	0.52	-0.38	-0.25	0.88	0.18		0.22	0.15	-0.76	-0.4	0.14	-0.42
Short Long Term Debt Total	-0.44	0.16	-0.51	0.48	0.59	-0.01	-0.41	-0.31	0.16	-0.42	-0.22	-0.34	-0.53	-0.13	-0.41	-0.19	-0.14	0.49	-0.26	0.22		0.02	-0.49	-0.19	0.98	0.18
Net Receivables	-0.16	-0.37	0.09	0.28	-0.24	0.0	-0.23	-0.11	-0.24	-0.24	0.08	-0.4	0.3	-0.28	-0.22	0.02	-0.4	0.16	-0.11	0.15	0.02		-0.05	-0.39	-0.05	-0.46
Good Will	0.66	0.3	0.51	0.34	0.35	-0.09	-0.45	0.74	-0.44	-0.44	0.47	-0.22	-0.26	0.44	-0.45	0.54	0.49	-0.69	0.01	-0.76	-0.49	-0.05		0.56	-0.46	0.45
Non Current Liabilities Total	0.41	0.77	-0.24	0.27	0.48	-0.35	-0.32	0.46	0.08	-0.31	0.08	-0.26	-0.62	0.7	-0.28	0.11	0.96	-0.39	0.47	-0.4	-0.19	-0.39	0.56		-0.22	0.91
Inventory	-0.45	0.13	-0.49	0.45	0.6	-0.07	-0.4	-0.32	0.18	-0.4	-0.26	-0.27	-0.56	-0.16	-0.4	-0.21	-0.19	0.43	-0.32	0.14	0.98	-0.05	-0.46	-0.22		0.16
Short Term Debt	0.34	0.84	-0.28	0.46	0.77	-0.25	-0.51	0.44	0.01	-0.49	0.13	-0.39	-0.83	0.65	-0.47	0.19	0.89	-0.28	0.3	-0.42	0.18	-0.46	0.45	0.91	0.16

Click cells to compare fundamentals

Cocrystal Pharma Account Relationship Matchups

Cocrystal Pharma fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	54.2M	79.4M	40.8M	31.3M	35.9M	68.2M
Total Current Liabilities	1.4M	1.5M	1.2M	3.3M	2.9M	2.7M
Total Stockholder Equity	52.5M	77.5M	39.6M	26.4M	30.3M	42.6M
Net Debt	(32.4M)	(58.2M)	(36.8M)	(24.5M)	(22.1M)	(20.9M)
Retained Earnings	(244.9M)	(259.1M)	(297.9M)	(315.9M)	(284.3M)	(270.1M)
Accounts Payable	657K	578K	614K	1.2M	1.4M	931.8K
Cash	33.0M	58.7M	37.1M	26.4M	30.3M	31.8M
Non Current Assets Total	20.2M	20.1M	662K	2.2M	2.5M	2.4M
Cash And Short Term Investments	33.0M	58.7M	37.1M	26.4M	30.3M	31.8M
Common Stock Shares Outstanding	55.2M	88.4M	8.1M	9.7M	11.1M	13.1M
Liabilities And Stockholders Equity	54.2M	79.4M	40.8M	31.3M	35.9M	68.2M
Other Stockholder Equity	297.3M	336.5M	337.5M	342.3M	393.6M	413.3M
Total Liab	1.7M	1.8M	1.3M	4.9M	4.4M	4.2M
Total Current Assets	34.0M	59.3M	40.2M	29.1M	33.5M	35.1M
Common Stock	71K	98K	8K	10K	11.5K	10.9K
Other Current Liab	267K	495K	122K	1.8M	1.6M	1.7M
Property Plant And Equipment Net	1.1M	931K	616K	2.1M	2.4M	2.6M
Other Current Assets	449K	618K	2.3M	1.8M	2.1M	2.2M
Property Plant And Equipment Gross	1.1M	2.4M	2.2M	3.9M	4.5M	4.7M
Short Long Term Debt Total	596K	534K	297K	1.9M	1.7M	1.6M
Net Receivables	556K	0.0	716K	890K	1.0M	726.3K
Non Current Liabilities Total	379K	298K	57K	1.6M	1.5M	1.4M
Short Term Debt	434K	472K	480K	240K	216K	205.2K
Net Tangible Assets	6.6M	33.4M	58.5M	39.6M	35.6M	34.6M
Other Assets	544K	46K	0.0	1.0	0.9	0.86
Property Plant Equipment	1.1M	1.1M	931K	616K	708.4K	640.6K
Net Invested Capital	52.5M	77.5M	39.6M	26.4M	23.7M	45.1M

Pair Trading with Cocrystal Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Cocrystal Stock

0.59	XOM	Exxon Mobil Corp Aggressive Push	Pair Corr
0.54	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr
0.53	EYEN	Eyenovia	Pair Corr
0.52	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.45	NYXH	Nyxoah Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.

The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC